EUVIMEDEUVIMED entdecken
Crossref

‌Liquid–Liquid Phase Separation of AR Orchestrated by Melatonin Sensitizes Prostate Cancer to Ferroptosis Via MCM5/NRF2 Axis Collapse

Xianyanling Yi, Zeyu Han, Yaxiong Tang, Jin Li, Xuanji Li, Hang Xu, Xiaonan Zheng, Dazhou Liao, Hong Li, Qiang Wei, Lu Yang, Jianzhong Ai iD

Journal of Pineal Research · 2025

DOI: 10.1111/jpi.70094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pineal Research, 2025. Verfasst von Xianyanling Yi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Ferroptosis, NF-E2-Related Factor 2, Melatonin, Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of prostate cancer (PCa) remains challenging, and while melatonin (MEL) has demonstrated therapeutic potential, its precise mechanisms require further elucidation. Through integrated in vitro, in vivo, and bioinformatics analyses, this study demonstrated that MEL functioned as a novel ferroptosis inducer in PCa by disrupting androgen receptor (AR) liquid‐liquid phase separation (LLPS). We found that MEL effectively inhibited PCa proliferation, migration, and invasion in vitro while suppressing tumor growth safely in mice models. Mechanistically, MEL impaired AR LLPS dynamics, reducing AR‐driven transcription of minichromosome maintenance protein 5 (MCM5). MCM5 was a clinically relevant biomarker associated with aggressive PCa and poor survival. Crucially, downregulated MCM5 attenuated its physical interaction with NRF2, leading to uncontrolled activation of the NRF2/HMOX1 pathway, GPX4 suppression, and accumulation of ferroptosis hallmarks. These findings defined an AR/MCM5/NRF2 axis regulating ferroptosis susceptibility, establishing MEL as the first‐reported ferroptosis inducer that expands the mechanistic foundation and therapeutic potential of MEL‐based PCa treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNF-E2-Related Factor 2MelatoninProstatic NeoplasmsReceptors, AndrogenMaleAnimalsHumansMiceCell Line, TumorPhase Separation

Stichwörter der Autor:innen

MCM5ferroptosisliquid–liquid phase separationmelatoninprostate cancer

Substanzen

NF-E2-Related Factor 2MelatoninNFE2L2 protein, humanReceptors, AndrogenAR protein, human

Autor:innen und Institutionen

  • Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Urology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.

ORCID-Profile: Jianzhong Ai

Zitieren

APA

Yi, X., Han, Z., Tang, Y., Li, J., Li, X., Xu, H., Zheng, X., Liao, D., Li, H., Wei, Q., Yang, L., & Ai, J. (2025). ‌Liquid–Liquid Phase Separation of AR Orchestrated by Melatonin Sensitizes Prostate Cancer to Ferroptosis Via MCM5/NRF2 Axis Collapse. Journal of Pineal Research. https://doi.org/10.1111/jpi.70094

Vancouver

Yi X, Han Z, Tang Y, Li J, Li X, Xu H, et al. ‌Liquid–Liquid Phase Separation of AR Orchestrated by Melatonin Sensitizes Prostate Cancer to Ferroptosis Via MCM5/NRF2 Axis Collapse. Journal of Pineal Research. 2025. doi:10.1111/jpi.70094

BibTeX
@article{Yi2025,
  author = {Yi, Xianyanling and Han, Zeyu and Tang, Yaxiong and Li, Jin and Li, Xuanji and Xu, Hang and Zheng, Xiaonan and Liao, Dazhou and Li, Hong and Wei, Qiang and Yang, Lu and Ai, Jianzhong},
  title = {‌Liquid–Liquid Phase Separation of AR Orchestrated by Melatonin Sensitizes Prostate Cancer to Ferroptosis Via MCM5/NRF2 Axis Collapse},
  journal = {Journal of Pineal Research},
  year = {2025},
  doi = {10.1111/jpi.70094}
}
Kostenlos starten →